Acura Pharmaceuticals, Inc. (ACUR) Swings to Q2 Loss of 5c/Share
Get Alerts ACUR Hot Sheet
Join SI Premium – FREE
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) reported Q2 EPS of ($0.05), versus $0.35 reported last year.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!